Immatics (IMTX) Other financing activities (2019 - 2024)
Immatics (IMTX) posted Other financing activities of -$201.9 million for Q4 2024, down 692.04% sequentially from $34.1 million in Q3 2024, and down 125.49% YoY from $792.1 million in Q1 2024.
Immatics (IMTX) Other financing activities (2019 - 2024) Analysis & Trends
Immatics has reported Other financing activities for 6 years, with the latest figure at -$201.9 million in Q4 2024.
- Quarterly Other financing activities fell 125.49% year-over-year to -$201.9 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.6 million (up 823.53% YoY) and the FY2024 annual result came in at $256241.4, up 8.43% from the prior year.
- Other financing activities slipped to -$201.9 million in Q4 2024 per IMTX's latest filing, from $34.1 million in the prior quarter.
- Over five years, Other financing activities peaked at $244.0 billion in Q3 2020 and troughed at -$247.4 billion in Q4 2020.
- A 5-year average of -$300.3 million and a median of -$30.1 million in 2022 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2020 and 2023: Other financing activities jumped 43784.24% in 2020, then tumbled 197.25% in 2023.
- Over 5 years, Other financing activities stood at -$247.4 billion in 2020, then soared by 99.77% to -$581.4 million in 2021, then jumped by 94.82% to -$30.1 million in 2022, then sank by 197.25% to -$89.5 million in 2023, then plunged by 125.49% to -$201.9 million in 2024.
- According to Business Quant data, Other financing activities over the past three periods registered -$201.9 million, $34.1 million, and $38.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -201.92 Mn |
| Dec 31, 2024 | -201.92 Mn |
| Sep 30, 2024 | 34.11 Mn |
| Sep 30, 2024 | 34.11 Mn |
| Jun 30, 2024 | 38.82 Mn |
| Jun 30, 2024 | 38.82 Mn |
| Mar 31, 2024 | 132.64 Mn |
| Mar 31, 2024 | 132.64 Mn |
| Dec 31, 2023 | -89.55 Mn |
| Dec 31, 2023 | -89.55 Mn |
| Sep 30, 2023 | -51.12 Mn |
| Sep 30, 2023 | -51.12 Mn |
| Jun 30, 2023 | 13.60 Mn |
| Jun 30, 2023 | 13.60 Mn |
| Mar 31, 2023 | 126.57 Mn |
| Mar 31, 2023 | 126.57 Mn |
| Dec 31, 2022 | -30.13 Mn |
| Dec 31, 2022 | -30.13 Mn |
| Sep 30, 2022 | -87.80 Mn |
| Sep 30, 2022 | -87.80 Mn |